Cellular Specificity of NF-κB Function in the Nervous System.

Dresselhaus EC, Meffert MK. · 2019

Read Cellular Specificity of NF-κB Function in the Nervous System. by Dresselhaus EC, Meffert MK. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6520659.txt.

Introduction

Dresselhaus and Meffert review cell-specific roles of NF-κB in the nervous system. Their review appeared in Frontiers in Immunology. NF-κB is a transcription factor found in nearly all cells. Its roles in immunity and cancer are well mapped. Its basic roles in the brain are less clear.

The brain holds many cell types, and each may use NF-κB in its own way. The authors separate cell-autonomous control from wider effects. They review work in neurons first. Then they turn to glial cells, astrocytes and microglia among them. Normal function and disease states both get covered. Subunit and cell-type detail runs through the piece.

Catalog record

CREATORDresselhaus EC, Meffert MK.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE74 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6520659

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Cellular Specificity of NF-κB Function in the Nervous System By Erica C. Dresselhaus, Mollie K. Meffert Published in: Frontiers in Immunology DOI: 10.3389/fimmu.2019.01043 ABSTRACT Nuclear Factor Kappa B (NF-κB) is a ubiquitously expressed transcription factor with key functions in a wide array of biological systems. While the role of NF-κB in processes, such as host immunity and oncogenesis has been more clearly defined, an understanding of the basic functions of NF-κB in the nervous system has lagged behind. The vast cell-type heterogeneity within the central nervous system (CNS) and the interplay between cell-type specific roles of NF-κB contributes to the complexity of understanding NF-κB functions in the brain. In this review, we will focus on the emerging understanding of cell-autonomous regulation of NF-κB signaling as well as the non-cell-autonomous functional impacts of NF-κB activation in the mammalian nervous system. We will focus on recent work which is unlocking the pleiotropic roles of NF-κB in neurons and glial cells (including astrocytes and microglia). Normal physiology as well as disorders of the CNS in which NF-κB signaling has been implicated will be discussed with reference to the lens of cell-type specific responses. BACKGROUND Mammalian NF-κB functions as a dimer composed of five potential Rel/NF-κB family subunits that can be divided into two classes. Rel A (p65), c-Rel, and Rel B are synthesized as mature proteins which contain transcription transactivation domains (TADs). The remaining subunits, p50 and p52, are post-translationally cleaved from the precursor proteins p105 (NFKB1) and p100 (NFKB2), respectively, and lack TADs (1). NF-κB subunits can hetero- or homo-dimerize; while all subunits have been reported to be expressed in different brain cell types, the p50:p65 dimer appears widely abundant to date. In unstimulated conditions, NF-κB dimers are held latent mainly in the cytoplasm by binding to a set of proteins from the “inhibitor of kB” (IκB) family. Following cellular stimulation by growth factors, excitatory synaptic transmission, immune-modulatory factors, or other activators, the IκB inhibitors undergo post-translational modification and ultimately degradation through well-studied steps which have been reviewed in detail elsewhere (2). These steps may be broadly categorized into either an alternative pathway or the “cannonical pathway” (CP) in which IκB phosphorylation is mediated by the IκB kinase complex (IKK). In the CP, NF-κB activation occurs when incoming cellular stimuli connect to signaling assemblies mediating IKK activation. IKK activation leads to IκB inhibitor phosphorylation on critical serine residues, followed by ubiquitination and proteasomal degradation, which frees the NF-κB dimer to undergo stable translocation into the cellular nucleus and regulate transcription of genes containing consensus κB binding sites in the DNA of their enhancers or promoters. NF-κB-mediated transcription has also been reported to be enhanced through phosphorylation of the Rel proteins (3). Studies in the nervous system have assessed several aspects of the pathway as proxies to monitor NF-κB activation, including accumulation of Rel proteins in the nucleus and Rel phosphorylation, as well as the classical reduction in IκB protein levels and accompanying induction of NF-κB-DNA binding activity (e.g., by electromobility shift assay, EMSA). Multiple approaches have also been used to test roles for NF-κB in molecular and behavioral studies of brain function. Mutation of the serine residues critical for IκBα phosphorylation and degradation has been used to engineer a dominant-negative “super-repressor” (DN-IκB) transgene that exerts blockade of the NF-κB activation pathway (4), and constitutively active variants of IKK (CA-IKK) have been used to produce genetically controlled NF-κB pathway activation. Viral expression constructs and mouse lines enabling selective expression of the DN-IκB and CA-IKK have also been effective tools in dissecting cell-type specific roles of NF-κB in the CNS. Mouse lines engineered to allow site-specific recombination using Cre-lox systems should become particularly useful in allowing neuroscientists to define endogenous gene function for members of the Rel family in discrete brain regions, cell types, and developmental periods. In the following sections, we will review studies which incorporate multiple approaches to define our current understanding of NF-κB function in the mammalian nervous system during both health and disease, with a particular focus on the complexity of cell-type and subunit-specific roles. Normal Physiology The heterogeneous cellular composition of the brain has presented a major challenge to understanding the effects of NF-κB pathway activation in single cells as well as its role in cognitive function of the brain as a whole. Comparative studies of NF-κB in the many rare cell types of the CNS remains uncharted territory. However, to appreciate the overall impacts of signaling through the NF-κB pathway on brain health and function it is nonetheless instructive to consider more general assessments of activation and function in neurons vs. glia. Effective promoters for driving cell-type selective manipulations of the NF-κB signaling pathway exist for neurons but have until very recently hampered studies of glial-specific roles, as discussed below. Partially due to this limitation, more of the existing evidence for discrete cell-type and subunit-specific roles of NF-κB activation has emerged from selective pathway manipulations in neurons. NEURONS There are likely hundreds of different types of neurons within the mammalian CNS, depending upon the classification method (5). Broad neuronal categories in which NF-κB function has been investigated include both excitatory (glutamatergic) and inhibitory (GABAergic) neurons, as well as the neuronal subcompartment of the synapse, the sites where connections between neurons are made. A broad range of stimuli are documented to activate neuronal NF-κB, ranging from well-known inflammatory mediators, to stimuli whose action may participate more selectively in NF-κB signaling in neurons, such as the growth factors neuronal growth factor (NGF) and Brain-derived growth factor (BDNF) and excitatory neurotransmitters (6). In addition to selective induction pathways, there are also multiple functional readouts of NF-κB activation on both the cellular and behavioral level which appear to be specific for the neuronal population of NF-κB. Three members of the NF-κB family, p50 (7–9), c-Rel (10–12), and p65/RelA (13, 14), as well as IKK (15), have been implicated in regulating cognitive behaviors in mice, including learning and memory. However, most of the studies examining NF-κB subunit-specific effects on behavior have not been carried out in a cell-type selective manner, and have instead used mouse models ubiquitously lacking particular subunits which could have phenotype contributions from loss of NF-κB outside the nervous system, such as immunological deficits. Neuron-selective disruption of NF-κB signaling [by DN-IKK expression predominantly in either forebrain excitatory neurons (16) or GABAergic interneurons] (17) has confirmed essential roles for NF-κB in a variety of assays of synaptic plasticity as well as mammalian cognitive behavior tasks. However, such NF-κB pathway manipulation does not deliver subunit specific information. Several informative reviews on cognitive effects of NF-κB signaling have been published (18–21), and we will not dwell further on this topic here. Activation of the NF-κB signaling pathway by excitatory neurotransmission and its participation in multiple forms of structural and synaptic plasticity is likely a basis for the function of this transcription factor in cognitive behaviors. Deficits in NF-κB signaling have been shown to produce impairments in in vitro assays of long-term plasticity, including long-term potentiation (LTP) (9, 10, 17, 22) and long-term depression (LTD) (12). Activation of the NF-κB pathway in murine excitatory glutamatergic neurons promotes dendritic spine and excitatory synapse formation (23), while diminished NF-κB activity (loss of RelA/p65) reduces dendritic spine

Read the complete text